This observation suggests that in cancer, YAP and TAZ are activated either through Hippo-independent pathways downstream of multiple stimuli and oncogenic proteins in cancer cells, or by alternative inputs, such as the cytoskeleton and cell–cell junctions, which play key roles in YAP/TAZ regulation without genetic or epigenetic alterations [40,41]. Here, YAP1 is linked to cancer.